Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability

Stopped early · Phase 3

Conditions studied: Acute Myocardial Infarction

In brief

This is a randomized trial investigating the use of the IMPELLA RECOVER LP 2.5 compared to Intra-aortic balloon pump (IABP) in patients with Acute Myocardial Infarction.

Key facts

Study ID

NCT00972270

Run by

Abiomed Inc.

People needed

1

Starts

2008-07-01

Expected to finish

2010-09-01

Last updated by the study team

2011-03-21

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Informed Consent
• Subject presenting with STEMI undergoing primary PCI
• Patient presents with at least 1 of the following:
• Unstable blood pressure
• Tachycardia and tissue hypoperfusion
• The need for intravenous pressor or inotropic support
• Patient presents with STEMI:
• CK-MB>2x normal

You may not qualify if…

• Unwitnessed cardiac arrest
• Abnormalities of the aorta
• Recent stroke or TIA
• Mural thrombus in the left ventricle

Where it is running

• Hartford Hospital — Hartford, Connecticut, United States
• University of Chicago Medical Center — Chicago, Illinois, United States
• Shawnee Mission — Shawnee Mission, Kansas, United States
• Valley Hospital — Hawthorne, New Jersey, United States
• Ohio State University — Columbus, Ohio, United States
• Riverside Methodist — Columbus, Ohio, United States
• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
• Pinnacle Health — Wormleysburg, Pennsylvania, United States
• York Hospital — York, Pennsylvania, United States
• Methodist Hospital — Houston, Texas, United States
• Intermountain Medical Center — Murray, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.